UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

The effects of Italian Mediterranean organic diet (IMOD) on health status

Current pharmaceutical design, 2010-03, Vol.16 (7), p.814

2010

Link zum Volltext

Verfügbarkeit prüfen

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

Cell death & disease, 2016-02, Vol.7 (2), p.e2120-e2120

2016

Link zum Volltext

Verfügbarkeit prüfen

Alpha-lipoic acid supplementation: a tool for obesity therapy?

Current pharmaceutical design, 2010-03, Vol.16 (7), p.840

2010

Link zum Volltext

Verfügbarkeit prüfen

Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome

Current pharmaceutical design, 2008-09, Vol.14 (26), p.2699

2008

Link zum Volltext

Verfügbarkeit prüfen

Acouphènes et aptitude au poste. À propos de cas concrets

Archives des maladies professionnelles et de l'environnement, 2014-06, Vol.75 (3), p.S1-S1

2014

Link zum Volltext

Verfügbarkeit prüfen

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

Cancer chemotherapy and pharmacology, 2008-09, Vol.62 (4), p.621-629

2008

Link zum Volltext

Verfügbarkeit prüfen

Body composition analyses in normal weight obese women

European review for medical and pharmacological sciences, 2006-07, Vol.10 (4), p.191

2006

Link zum Volltext

Verfügbarkeit prüfen

489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts

Annals of oncology, 2021-09, Vol.32, p.S573-S573

2021

Link zum Volltext

Verfügbarkeit prüfen

Is antioxidant plasma status in humans a consequence of the antioxidant food content influence?

European review for medical and pharmacological sciences, 2007-05, Vol.11 (3), p.185

2007

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft

British journal of cancer, 2000, Vol.82 (2), p.480-487

2000

Link zum Volltext

Verfügbarkeit prüfen

1938P - Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Annals of oncology, 2019-10, Vol.30, p.v781-v782

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Annals of oncology, 2019-10, Vol.30, p.v781-v782

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of Interleukin-15 Receptor α Polymorphisms in Normal Weight Obese Syndrome

International journal of immunopathology and pharmacology, 2009, Vol.22 (1), p.105-113

2009

Link zum Volltext

Verfügbarkeit prüfen

Novel anthracycline oligosaccharides: Influence of chemical modifications of the carbohydrate moiety on biological activity

Bioorganic & medicinal chemistry, 2002-05, Vol.10 (5), p.1459-1470

2002

Link zum Volltext

Verfügbarkeit prüfen

Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts

Clinical cancer research, 1998-11, Vol.4 (11), p.2833-2839

1998

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: Relationship to body composition and IL-1 α and β plasma levels

Pharmacological research, 2007-02, Vol.55 (2), p.131-138

2007

Link zum Volltext

Verfügbarkeit prüfen

Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231

Anti-cancer drugs, 2005-11, Vol.16 (10), p.1083-1089

2005

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice

European journal of cancer (1990), 2001-02, Vol.37 (3), p.431-437

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor

The Journal of steroid biochemistry and molecular biology, 2003-04, Vol.84 (5), p.503-512

2003

Link zum Volltext

Verfügbarkeit prüfen

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat

European journal of pharmacology, 2001-02, Vol.414 (1), p.71-78

2001

Link zum Volltext

Verfügbarkeit prüfen

CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival

International journal of cancer, 2004-01, Vol.108 (3), p.390-398

2004

Link zum Volltext

Verfügbarkeit prüfen

Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation

Molecular pharmacology, 1996-09, Vol.50 (3), p.603

1996

Link zum Volltext

Verfügbarkeit prüfen

1938PCharacterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Involvement of nitric oxide in both central and peripheral haemodynamic effect of d/ l-nebivolol and its enantiomers in rats

European journal of pharmacology, 2005-03, Vol.511 (2), p.167-174

2005

Link zum Volltext

Verfügbarkeit prüfen

Topoisomerase Poisoning Activity of Novel Disaccharide Anthracyclines

Molecular pharmacology, 1999-07, Vol.56 (1), p.77-84

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(33)
Humans
(31)
Pharmacology & Pharmacy
(20)
Female
(18)
Animals
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Mice
(13)
Pharmacology. Drug Treatments
(13)
Oncology
(11)
Physical Sciences
(11)
Antineoplastic Agents
(10)
Chemistry
(10)
Mice, Nude
(10)
Adult
(9)
Antineoplastic Agents - Pharmacology
(8)
Body Mass Index
(8)
Male
(8)
Middle Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effects of Italian Mediterranean organic diet (IMOD) on health status

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

Alpha-lipoic acid supplementation: a tool for obesity therapy?

Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome

Acouphènes et aptitude au poste. À propos de cas concrets

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

Body composition analyses in normal weight obese women

489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts

Is antioxidant plasma status in humans a consequence of the antioxidant food content influence?

Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft

1938P - Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Characterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Role of Interleukin-15 Receptor α Polymorphisms in Normal Weight Obese Syndrome

Novel anthracycline oligosaccharides: Influence of chemical modifications of the carbohydrate moiety on biological activity

Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts

Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: Relationship to body composition and IL-1 α and β plasma levels

Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231

Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice

Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat

CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival

Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation

1938PCharacterization of the mechanism of action and efficacy of MEN1611 (PA799), a novel PI3K inhibitor, in breast cancer preclinical models

Involvement of nitric oxide in both central and peripheral haemodynamic effect of d/ l-nebivolol and its enantiomers in rats

Topoisomerase Poisoning Activity of Novel Disaccharide Anthracyclines

Suchergebnisse filtern